ClinicalTrials HQ

Combination Immunotherapy in Rare Cancers Under InvesTigation

Combination Immunotherapy in Rare Cancers Under InvesTigation

Active, not recruiting · NCT04969887 · Registry updated 2026-02-27
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Combination Immunotherapy in Rare Cancers Under InvesTigationFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, female reproductive system disorder, female reproductive system neoplasm, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumorActive, not recruitingPhase 22026-02-27NCT04969887

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bristol-Myers Squibb422
Olivia Newton-John Cancer Research Institute8

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Auckland City HospitalAucklandNew Zealand23
Austin HealthHeidelbergAustralia70
Barwon HealthGeelongAustralia2
Bendigo Health ServicesBendigoAustralia1
Blacktown HospitalSydneyAustralia1
Border Medical Oncology UnitAlburyAustralia1
Cairns And Hinterland Hospital And Health ServiceCairnsAustralia2
Calvary Mater NewcastleWaratahAustralia49
Fiona Stanley HospitalPerthAustralia5
Goulburn Valley HealthSheppartonAustralia8
Orange Health ServiceOrangeAustralia1
Peninsula HealthFrankstonAustralia2
Peter MacCalllum Cancer CentreParkvilleAustralia1
Royal Adelaide HospitalAdelaideAustralia10
Royal Hobart HospitalHobartAustralia44
South West HealthcareWarrnamboolAustralia1
Townsville Hospital and Health ServiceDouglasAustralia2
Townville Hospital and Health ServiceTownsvilleAustralia1